Webinar – Preparing a Successful ICER Strategy: Lessons from the Frontlines
How do you prepare for a successful ICER strategy? We asked three industry experts what the key components of a successful ICER evaluation strategy are and what manufacturers need to do to prepare. Our webinar panelists bring three unique perspectives of the ICER evaluation process and share their lessons learned along the way. Check out […]
You Can Influence ICER Recommendations, You Just Need the Right Evidence
It’s difficult to dispute the findings of an advisory group which is widely accepted as the authority, especially when it comes to evaluating the value of different therapeutic interventions. The cost of drugs in the US has been a hot button topic in recent years, so healthcare industry stakeholders are increasingly looking for objective […]
ICER’s Development and Use of RWE: 5 Areas for Concern
The pervasiveness of real-world data (RWD) and the need to understand outcomes in clinical practice have galvanized the ubiquity and utility of real-world evidence (RWE). Especially within the life sciences industry, RWE is increasingly leveraged by research and development, epidemiology, outcomes research, and commercial groups across an asset’s lifecycle to strengthen product evidence and value […]